InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,306.00
(
-0.15%
)
Dow Jones
42,025.19
(
0.00%
)
Brent Oil
73.94
(
-0.52%
)
Bitcoin
63,524.88
(
0.91%
)
Post# of 253160
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: oc631 post# 137902

Sunday, 02/26/2012 11:31:55 AM

Sunday, February 26, 2012 11:31:55 AM

Post# of 253160

If GS-7977/Riba has viral relapse problems in GT1 treatment-naive patients it could be a wildly bullish event for Medivir.

When are these results due?

Positive data for 7977/Riba in GT1's shouldn't cause significant downside for Medivir so in this respect it would be good trade IMO.

I'm inclined to agree because I think the goal is to ultimately remove riba as well. I think this is another reason why the 7977+TMC435 combo study is so important because they are testing both drugs with and without riba (http://www.medivir.se/v4/en/ir_media/pressrelease.cfm?year=2011&releaseid=587686 ).
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up